Why does semaglutide have great potential in China?

1. Large number of patients and sufficient demand: domestic diabetes patients have a large base, and the corresponding drug market is large. In addition, people are paying more and more attention to weight loss treatment. Smeglutide can cover these two types of needs, and the market space is wide.

2. Clinically effective and recognized: Not only can it effectively lower blood sugar and help with weight loss, but clinical studies have also confirmed its protective effect on cardiovascular health, which has been recommended by medical guidelines.

3. Domestic pharmaceutical companies are making efforts: Many domestic pharmaceutical companies have made progress in biosimilars or improved new drugs of semaglutide, and several companies' market applications have been accepted, all hoping to launch products as soon as possible.

4. It will be cheaper in the future: When domestic drugs similar to semaglutide may enter centralized procurement in the future, the price is likely to significantly decrease. Even the original drug is now adjusting its pricing strategy, making it increasingly affordable for the general public.

5. Guaranteed production capacity and supply: Domestic raw material pharmaceutical companies have made breakthroughs in peptide scale production technology, and original research drug companies and generic drug companies are also accelerating product launch and commercialization through cooperation, ensuring sufficient supply in the market.